TFS CAPITAL LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 1.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2016$755,000
-18.6%
46,859
-39.4%
0.14%
+3.7%
Q1 2016$928,000
-75.0%
77,360
-70.3%
0.13%
-66.4%
Q4 2015$3,706,000
-17.2%
260,426
-32.0%
0.40%
-7.6%
Q3 2015$4,478,000
-19.3%
383,030
+21.4%
0.43%
-20.3%
Q2 2015$5,546,000
+20.1%
315,495
+2.2%
0.54%
+19.9%
Q1 2015$4,617,000
+2750.0%
308,624
+2106.5%
0.45%
+2913.3%
Q4 2014$162,000
-27.0%
13,987
-26.7%
0.02%
-21.1%
Q3 2014$222,00019,0870.02%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2016
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders